On one hand, to sustain rapid proliferation, cancer cells actively reprogram iron metabolism pathways by upregulating iron import proteins such as TFR1 and DMT1, while downregulating the FPN, thereby increasing intracellular Fe2+ uptake, which in turn promotes mitochondrial function, DNA synthesis, and cell cycle progression (84). This evidence concerns the gene TFRC and cancer.